During the past decade, Southcoast Health System conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Southcoast Health System" are "Carcinoma, Non-Squamous Non-Small Cell Lung" (1 trials), "Non-small Cell Lung Cancer" (1 trials) and "Non-small Cell Lung Cancer (NSCLC)" (1 trials). Many other conditions were trialed in "Southcoast Health System" in a lesser frequency.

Most popular intervention types in "Southcoast Health System" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials), "Carboplatin" (1 trials), "Durvalumab" (1 trials) and "Nab-Paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southcoast Health System" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Southcoast Health System". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Southcoast Health System, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Southcoast Health System, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".